- Home
- ATER vs ASBP Comparison
ATER vs ASBP Comparison
Compare ATER & ASBP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ATER
- ASBP
- Stock Information
- Founded
- ATER 2014
- ASBP 2021
- Country
- ATER United States
- ASBP United States
- Employees
- ATER N/A
- ASBP N/A
- Industry
- ATER Home Furnishings
- ASBP Biotechnology: Pharmaceutical Preparations
- Sector
- ATER Consumer Discretionary
- ASBP Health Care
- Exchange
- ATER Nasdaq
- ASBP Nasdaq
- Market Cap
- ATER 15.5M
- ASBP 14.5M
- IPO Year
- ATER N/A
- ASBP N/A
- Fundamental
- Price
- ATER $1.26
- ASBP $0.37
- Analyst Decision
- ATER
- ASBP
- Analyst Count
- ATER 0
- ASBP 0
- Target Price
- ATER N/A
- ASBP N/A
- AVG Volume (30 Days)
- ATER 66.5K
- ASBP 930.6K
- Earning Date
- ATER 08-13-2025
- ASBP 08-24-2025
- Dividend Yield
- ATER N/A
- ASBP N/A
- EPS Growth
- ATER N/A
- ASBP N/A
- EPS
- ATER N/A
- ASBP N/A
- Revenue
- ATER $94,191,000.00
- ASBP N/A
- Revenue This Year
- ATER N/A
- ASBP N/A
- Revenue Next Year
- ATER $7.48
- ASBP N/A
- P/E Ratio
- ATER N/A
- ASBP N/A
- Revenue Growth
- ATER N/A
- ASBP N/A
- 52 Week Low
- ATER $1.15
- ASBP $0.22
- 52 Week High
- ATER $3.84
- ASBP $15.80
- Technical
- Relative Strength Index (RSI)
- ATER 43.43
- ASBP N/A
- Support Level
- ATER $1.16
- ASBP N/A
- Resistance Level
- ATER $1.21
- ASBP N/A
- Average True Range (ATR)
- ATER 0.05
- ASBP 0.00
- MACD
- ATER 0.00
- ASBP 0.00
- Stochastic Oscillator
- ATER 44.00
- ASBP 0.00
About ATER Aterian Inc.
Aterian Inc is a technology-enabled consumer products company. Its product categories include home and kitchen appliances, kitchenware, environmental appliances (dehumidifiers and air conditioners), beauty-related products and, consumer electronics. It has various owned and operates brands, including HomeLabs, Squatty Potty, Healing Solutions, PurSteam, and others. The company generates revenue through the online sales of various consumer products that are sold online.
About ASBP Aspire Biopharma Holdings Inc. Common Stock
Aspire Biopharma Holdings Inc developing next-generation absorption of medicine that will have an impact on the opioid crisis. The group engaged in the business of developing and marketing disruptive technology for novel delivery mechanisms for do-no-harm drugs. Its nanotechnology drug formulation directly targets pain and inflammation bypassing the gastrointestinal tracts.